Prospective randomized trial of paclitaxel alone versus 5-fluorouracil doxorubicin/cyclophosphamide as induction therapy in patients with operable breast cancer

Seminars in Oncology

Volumn 24, Issue 5 SUPPL. 17, 1997, Pages

  Buzdar, A U ^a   Hortobagyi, G N ^a   Asmar, L ^a   Theriault, R L ^a   Rahman, Z ^a   McNeese, M ^a   Singletary, S ^a   Ames, F ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; PACLITAXEL;

ADULT; AGED; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FEVER; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; NEUTROPENIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEPSIS;

ADULT; AGED; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; PACLITAXEL; PROSPECTIVE STUDIES;

EID: 0030667090     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (5)